Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | FAP | Q12884 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4814139 | 0.91 | DPP4 (0.78) | DPP4CYP3A4FAP | |
| SCHEMBL4808716 | 0.91 | DPP4 (0.59) | DPP4 | |
| SCHEMBL14045481 | 0.90 | DPP4 (0.67) | DPP4KCNH2CYP3A4FAP | |
| SCHEMBL14045473 | 0.85 | DPP4 (0.82) | DPP4CYP3A4FAP | |
| SCHEMBL8284557 | 0.83 | DPP4 (0.60) | DPP4CYP3A4 | |
| SCHEMBL14045483 | 0.83 | DPP4 (0.66) | DPP4KCNH2CYP3A4FAP | |
| SCHEMBL8283500 | 0.83 | DPP4 (0.78) | DPP4CYP3A4FAP | |
| SCHEMBL14148871 | 0.82 | DPP4 (0.60) | DPP4KCNH2CYP3A4FAP | |
| SCHEMBL14148451 | 0.81 | DPP4 (0.62) | DPP4CYP3A4 | |
| SCHEMBL8283523 | 0.80 | DPP4 (0.54) | DPP4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7432262-B2 | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-10-07 | — | — | US | disclosed |
| US-20070142383-A1 | Imidazopyridazinediones, Their Preparation And Their Use As Pharmaceutical Compositions | ECKHARDT MATTHIAS | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142383-A1 | Imidazopyridazinediones, Their Preparation And Their Use As Pharmaceutical Compositions | DPP4, DPP3, DPP7 | DPP4 1/4885KCNH2 1876/4885CYP3A4 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.